Modified cell lines for increasing lentiviral titers
US9284552B2 · kind B2 · utility
1Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2013 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Feb 5, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/15052
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides a method of modifying cells in order to enhance lentiviral titers, cell lines that are modified and modifying reagents. By mediating individual genes and combination thereof, lentiviral titers may be increased.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.